Patents by Inventor Jill-Desiree Brederson

Jill-Desiree Brederson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TO RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF
    Publication number: 20150307610
    Abstract: The present application relates to antibodies, such as monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, for the treatment and diagnosis of pain and other neuroinflammatory conditions associated with the Receptor for Advanced Glycation End Products (RAGE).
    Type: Application
    Filed: June 30, 2015
    Publication date: October 29, 2015
    Inventors: Marina I. Strakhova, Jill-Desiree Brederson
  • Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
    Patent number: 9067996
    Abstract: The present application relates to antibodies, such as monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, for the treatment and diagnosis of pain and other neuroinflammatory conditions associated with the Receptor for Advanced Glycation End Products (RAGE).
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 30, 2015
    Assignee: Abbvie Inc.
    Inventors: Marina I. Strakhova, Jill-Desiree Brederson
  • PARP INHIBITORS FOR THE TREATMENT OF CIPN
    Publication number: 20140093585
    Abstract: The present invention relates to the method of treating chemotherapy-induced neuropathy in a subject in need thereof with the use of a poly(ADP-ribose)polymerase (PARP) inhibitor.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Inventors: Vincent L. Giranda, Alexander R. Shoemaker, Kaitlin E. Browman, Shailen K. Joshi, Jill-Desiree Brederson
  • ANTIBODIES TO RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF
    Publication number: 20130189252
    Abstract: The present application relates to antibodies, such as monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, for the treatment and diagnosis of pain and other neuroinflammatory conditions associated with the Receptor for Advanced Glycation End Products (RAGE).
    Type: Application
    Filed: March 15, 2013
    Publication date: July 25, 2013
    Inventors: Marina I. Strakhova, Jill-Desiree Brederson
  • Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
    Patent number: 8420083
    Abstract: The present application relates to antibodies, such as monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, for the treatment and diagnosis of pain and other neuroinflammatory conditions associated with the Receptor for Advanced Glycation End Products (RAGE).
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: April 16, 2013
    Assignee: Abbvie Inc.
    Inventors: Marina I. Strakhova, Jill-Desiree Brederson
  • PARP INHIBITORS FOR THE TREATMENT OF CIPN
    Publication number: 20120258180
    Abstract: The present invention relates to the method of treating chemotherapy-induced neuropathy in a subject in need thereof with the use of a poly(ADP-ribose)polymerase (PARP) inhibitor.
    Type: Application
    Filed: April 9, 2012
    Publication date: October 11, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Vincent Louis Giranda, Alexander R. Shoemaker, Kaitlin E. Browman, Shailen K. Joshi, Jill-desiree Brederson, Thomas D. Penning
  • ANTIBODIES TO RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF
    Publication number: 20110104174
    Abstract: The present application relates to antibodies, such as monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, for the treatment and diagnosis of pain and other neuroinflammatory conditions associated with the Receptor for Advanced Glycation End Products (RAGE).
    Type: Application
    Filed: October 28, 2010
    Publication date: May 5, 2011
    Applicant: Abbott Laboratories
    Inventors: Marina I. Strakhova, Jill-Desiree Brederson